daunorubicin has been researched along with docetaxel anhydrous in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aita, P; Bearz, A; Boiocchi, M; Colussi, AM; Corona, G; Crivellari, D; Robieux, I; Sorio, R; Stocco, F; Toffoli, G | 1 |
| Brouwer, E; Nooter, K; Sparreboom, A; Stoter, G; van Zuylen, L; Verweij, J | 1 |
| Bernshausen, A; Bieler, A; Dravits, T; Gansbacher, B; Hartung, R; Holm, PS; Kaszubiak, A; Köhler-Vargas, N; Lage, H; Mantwill, K; Surowiak, P; Treiber, U | 1 |
| Gassner, B; Gekle, M; Kelleher, DK; Schwerdt, G; Thews, O | 1 |
| Chao, TY; Huang, TC | 1 |
| Bermingham, S; McMahon, GP; O'Connor, R; Regan, F | 1 |
| Chow, MS; Hao, J; Huang, Y; Lam, CW; Lau, B; Liu, M; Ravula, R; Shi, L; Song, Y; Wang, J; Wang, Z; Yeung, S | 1 |
| Hayakawa, A; Hirano, T; Kiyomi, A; Onda, K; Sugiura, M; Sugiyama, K; Takagi, N; Tanaka, S; Uematsu, N; Yuan, BO; Zhao, Y | 1 |
| Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
1 review(s) available for daunorubicin and docetaxel anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for daunorubicin and docetaxel anhydrous
| Article | Year |
|---|---|
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Daunorubicin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Idarubicin; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids; Time Factors | 2000 |
8 other study(ies) available for daunorubicin and docetaxel anhydrous
| Article | Year |
|---|---|
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Daunorubicin; Docetaxel; Drug Resistance, Multiple; Feces; Half-Life; Humans; Intestinal Mucosa; Metabolic Clearance Rate; Mixed Function Oxygenases; Neoplasms; Paclitaxel; Quinolines; Taxoids; Tumor Cells, Cultured | 2000 |
Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.
Topics: Adenoviridae; Adenovirus E2 Proteins; Animals; Antineoplastic Agents; Cell Nucleus; Combined Modality Therapy; Daunorubicin; DNA-Binding Proteins; Docetaxel; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, MDR; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Nuclear Proteins; Oncolytic Virotherapy; Promoter Regions, Genetic; Prostatic Neoplasms; Taxoids; Virus Replication; Xenograft Model Antitumor Assays; Y-Box-Binding Protein 1 | 2006 |
Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs.
Topics: Acidosis; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Daunorubicin; Docetaxel; Extracellular Space; Humans; Hydrogen-Ion Concentration; Hypoxia; Neoplasms; Rats; Taxoids | 2007 |
Mees lines and Beau lines after chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; Docetaxel; Female; Humans; Leukemia, Myeloid, Acute; Nail Diseases; Taxoids | 2010 |
Simultaneous determination of anthracyclines and taxanes in human serum using online sample extraction coupled to high performance liquid chromatography with UV detection.
Topics: Anthracyclines; Antineoplastic Agents; Blood Proteins; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Humans; Paclitaxel; Sensitivity and Specificity; Taxoids | 2010 |
Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Survival; Daunorubicin; Docetaxel; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Plant Extracts; Prostatic Neoplasms; Taxoids; Tripterygium | 2016 |
Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
Topics: Antineoplastic Agents; Arsenicals; Breast Neoplasms; Cell Culture Techniques; Cell Proliferation; Daunorubicin; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Spheroids, Cellular; Sulfides; Taxoids; Tissue Scaffolds | 2018 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |